- Home
- Healthcare Practice
- Clinical Practice Guidelines
- Antifungal Prophylaxis
Antifungal Prophylaxis
- 2020 CPG – Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients (open access at Journal of Clinical Oncology)
- Endorsed by the Children’s Oncology Group (COG)
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email:
Paula Robinson, MD, MSc
Senior Manager, Supportive Care and Guidelines
Antibacterial Prophylaxis
Antifungal Prophylaxis
Chemotherapy-Induced Nausea and Vomiting
Acute delayed Phase CINV
Anticipatory CINV
Breakthrough and Refractory CINV
Emetogenicity Classification
Acute and Delayed Phase CINV
Chronic Pain*
Clostridium Difficile Infection
Fatigue
Fertility Preservation*
Mucositis
Ototoxicity
Fever and Neutropenia
Food Restrictions
Platelet Transfusion*
Venous Thromboembolism*
Care Pathways


YOU can be a champion for kids with cancer!
With your help, we will ensure that kids and youth with cancer, their families and survivors of childhood cancer have equitable access to the best care for the best possible outcomes.